- Years of
experience - Direct
investments - IPOs &
M&As - Unicorns
and counting
We partner with exceptional teams who dare to dream big
XT Hi-Tech provides future category leaders with capital, advice, and support throughout their entire journey.
Detection engineering. Optimized.
Plant AI-based digital farming productivity platform
- ipo
Treating fine lines
and wrinkles
Connected care platform for medical devices
- ipo
Ingestible therapeutic platform
- acquired
Food ingredients and dietary supplements
We know what it takes, and we bring it to the table
For more than two decades, we’ve backed unique category leaders that emerged from Israel. When partnering, we see it as our mission to make the management teams as successful as possible, supporting them with capital, a broad network of connections, operational knowhow, and 24/7 advice - all based on decades of experience in taking companies from any stage to category leadership.
The Team
Udi Angel
Udi Angel has been a longtime investor and owner of various multi-billion dollar businesses. His entrepreneurial spirit, vast managerial experience, and personal network continuously contribute to XT Hi-Tech's evolution as a leading investor in Israeli technology companies.
Among other activities, he heads several communal and charitable organizations such as “Variety” Children’s Charity Israel (president), and Ruppin Academic Center (chairman of the Board of Governors).
Ori Angel
Ori Angel has been active in the technology investment space for years, investing in various categories at both early and growth stages. As a big believer in “technology-led” disruption, he leads the vision of XT Hi-Tech and its investment strategy direction.
Among his various activities, Ori is the CEO of XT maritime, a ship-owning company with over 120 employees and 2,500 seamen.
Ori holds a BS in Investment, Finance and Risk Management from London’s City University and MBA from University of Chicago’s Graduate School of Business. He graduated with honors from both institutions.
Bar Kozlovsky Associate
Bar joined XT Hi-Tech in September 2024, where she leads deal sourcing initiatives.
Prior to XT, she spearheaded business development at Pepper (a digital bank by Israel's Leumi Group), driving key growth strategies.
In addition to her corporate roles, Bar founded and led a small-business aid program through the 8200 alumni association, reflecting her entrepreneurial spirit and dedication to supporting local enterprises. Her commitment to social causes is also evident through her ongoing volunteer efforts.
Bar holds a BA in Psychology and Business Administration, and an MBA from Tel Aviv University, where she also served as a teaching assistant.
Chen Ben Hanania Research Analyst
Chen joined XT Hi-Tech in 2022 as a Research Analyst, researching categories and trends relevant to XT Hi-Tech and its portfolio companies. Prior to joining XT Hi-Tech, Chen worked as an Equity Research Analyst at Oppenheimer & Co, analyzing and providing financial insights on publicly traded companies in various industries. Prior to that, Chen was a Hedge Fund Analyst at Clover Wolf Capital.
Chen holds a B.A. in Financial Risk Management and a LL.B. from Reichman University in Herzliya, Israel.
Assif Stoffman Managing Director
Assif is a serial entrepreneur at heart, with over twenty years of experience in the software and healthcare industries. After holding various key positions at XT Hi-Tech, including heading its Venture Accelerator for several years where he was instrumental in supporting early stage startups from their very beginning, Assif co-founded, headed, and invested in several startups before rejoining XT Hi-Tech early 2020.
Currently, Assif is an active board member at Duve and BioT Medical. Notable previous investments include Checkmarx (acquired by Insight Venture Partners), CmyCasa (acquired by Adobe; NASDAQ: ADBE); MentorWave (acquired by Alphabet; NASDAQ: GOOG); and PainReform (NASDAQ: PRFX). In most of these cases, he joined the company at its earliest stages.
Assif holds an LL.M. (negotiation and dispute resolution program) from Bar-Ilan University and an LL.B and BA in Business Administration from The Interdisciplinary Center.
Yoav Sebba Managing Director
Yoav has been identifying, financing, and growing startup companies for over 20 years. Yoav joined the XT Group after serving as a partner in Yozma Venture Capital, one of Israel's anchor VC funds. Prior to Yozma, Yoav served as a project manager at one of Israel's leading commercial banks.
Yoav is an active board member in select XT Hi-Tech portfolio companies, where he leverages an extensive experience and global network to help them achieve their objectives and build value.
Currently, Yoav is serving on the board of Sofwave (TASE: SOFW), Phytech, Epitomee (TASE: EPIT), Cymbio, Healthy.io, Beyeonics, NeuReality, BlueThrone and ZIM (NYSE: ZIM). Previously, Yoav served on the boards of Cognitens (acquired by Hexagon), Kailight Photonics (acquired by Optium), Painreform (Nasdaq: PRFX), and NextNine (acquired by Honeywell).
Yoav holds an MBA from the Haifa University and BSc in Management and Industrial Engineering, cum laude, from the Technion Institute of Technology.
Investing in category leaders
Since the late 90s, we’ve seen waves of innovations, and took an active role in some big successes as well as in painful failures.
However, by carefully implementing our strategy, we managed to be a significant ingredient in the creation of market leaders like Checkmarx, Enzymotec, and Lumenis.
Our track record empowers us to invest in those companies we believe will be the next category leaders – even in categories that are still under construction…
Investing with passion
We invest only in companies where we are as excited about their mission as the management teams - and we are all super excited.
We believe in true partnerships, so before joining we try to learn how we can work together all the way, through highs and lows that are always part of the journey.
We have the deepest appreciation for the sacrifices made to build a company, so we offer management teams all, and only, the support they ask for, thus making sure we do not interfere in running the business. We believe this is key for a healthy, long-term partnership.
We will extend our management teams all the help they need, and we always cherish the sacrifice required to build a company
We believe all these are key for a healthy long-term partnership.
XT-backed companies
in the press
NeuReality lands $35M to bring AI accelerator chips to market
The funds will put toward finalizing the design of NeuReality’s flagship AI inferencing chip
First World’s App-aggregator Bluethrone Raises $6.5M in Seed from XT Hi-Tech
Bluethrone started buying apps in 2021 and has grown considerably since then
Hospitality tech startup Duve raises $10 million Series A
The investment was led by XT Hi-Tech and included the company's existing investors
PayPal Ventures Takes Stake in Commerce Automation Platform Cymbio
The investment comes four months after Cymbio announced a $20M Series B
Epitomee Medical completes $51m IPO on the Tel Aviv Stock Exchange
The offering was made at a pre-money valuation of $200m
BioT Raises $6.5m in Seed Round to accelerate the connected care revolution
BioT's SaaS platform for digital health IoT is set to transform healthcare
- All Articles